Cargando…

COVID Vaccination Rates in Children and Adults with Sickle Cell Disease in British Columbia, Canada

Background: Persons with Sickle Cell Disease (SCD) infected with the SARS CoV-2 virus have significantly increased risks of hospitalization and death and are strongly recommended to be fully vaccinated. Vaccine hesitancy has previously been described in the SCD population and uptake of other recomme...

Descripción completa

Detalles Bibliográficos
Autores principales:	Merkeley, Hayley, McGuire, Marlee, Ding, Lillian, McCartney, Heather, Amid, Ali, Strahlendorf, Caron, Sandhu, Nina, Vergidis, Dimitrios, O'Donnell, Maureen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society of Hematology. Published by Elsevier Inc. 2021
Materias:	904.Outcomes Research-Non-Malignant Conditions
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8701541/ http://dx.doi.org/10.1182/blood-2021-152141

Ejemplares similares

Venous Thromboembolism Post-COVID-19 Among Individuals with Sickle Cell Disease
por: Singh, Ashima, et al.
Publicado: (2021)

Clinical Course and Outcomes of Sickle Cell Disease Patients with COVID-19 at a New York Hospital
por: Mazloom, Anita, et al.
Publicado: (2020)

Pediatric Sickle Cell Disease and the COVID-19 Pandemic: A Year in Review at Children's National Hospital
por: Martin, Olufunke Y., et al.
Publicado: (2021)

COVID-19 and Sickle Cell Disease in the Province of Quebec: Morbidity and Mortality Rates Derived from the Provincial Registry
por: Castonguay, Mathias, et al.
Publicado: (2021)

Implementation and Preliminary Effectiveness of mHealth Apps for Improving Sickle Cell Disease Care during COVID-19: A Mixed-Methods Evaluation
por: Badawy, Sherif M., et al.
Publicado: (2021)

Use of Monoclonal Antibody Therapy in Hematologic Patients with Mild-to-Moderate COVID-19: A Retrospective Single-Center Experience
por: Amanam, Idoroenyi, et al.
Publicado: (2021)

Bleeding Complications in Patients with Cancer and COVID 19- Analysis from the COVID 19and Cancer Consortium (CCC19) Registry
por: Shah, Surbhi, et al.
Publicado: (2021)

Outcomes in Patients with Hematologic Disease and COVID-19 in Russia: Interim Analysis of CHRONOS19 Registry
por: Gavrilina, Olga A., et al.
Publicado: (2020)

Thrombotic Complications in COVID-19 Patients: Low Incidence of Thrombotic Complications Among Critically Ill COVID-19 Patients in Singapore
por: Lim, Cheryl XQ, et al.
Publicado: (2020)

Patient-Focused Benefits of at-Home Versus in-Clinic Administration of Cancer Therapy: New Considerations for the COVID-19 Era
por: Sandman, Karen E., et al.
Publicado: (2020)

The Impact of ABO Blood Group on Clinical Outcomes and Susceptibility in COVID-19: A Retrospective Population Study of 3305 Patients
por: Alduaij, Waleed, et al.
Publicado: (2020)

Incidence of Vascular Thromboembolic Events in Outpatients with Mild COVID-19
por: Eswaran, Harish, et al.
Publicado: (2020)

Real World Outcomes of Sars-Cov-2 Thrombosis Rates across Three University Health Systems in the Chicago Metropolitan Area
por: Berg, Stephanie, et al.
Publicado: (2020)

Incidence of and Risk Factors for Venous Thromboembolism Among Hospitalized Patients with Cancer and COVID-19: Report from the COVID-19 and Cancer Consortium (CCC19) Registry
por: Li, Ang, et al.
Publicado: (2020)

Assessment of Hematologic and Coagulation Parameters As Predictive Value in COVID-19 with Unfavourable Evolution
por: Popov, Viola Maria, et al.
Publicado: (2020)

Anticoagulant and Antiplatelet Use Not Associated with Improvement in Severe Outcomes in COVID-19 Patients
por: Ho, Gwendolyn, et al.
Publicado: (2020)

Association of Blood Type on Clinical Outcomes in Black/African Americans Hospitalized for COVID-19 Infection
por: Cheng, Yan, et al.
Publicado: (2020)

Incidence of Thrombosis and Associated Risk Factors in Hospitalized COVID-19 Patients in a New York City Hospital System
por: Theprungsirikul, Poy P., et al.
Publicado: (2020)

Severity of Sars-Cov-2 Infection in Patients with Hematologic Malignancies: A COVID-19 and Cancer Consortium (CCC19) Registry Analysis
por: Rubinstein, Samuel, et al.
Publicado: (2020)

Hematologic Characteristics of Surviving Versus Non-Surviving COVID-19 Patients in Critical Care Units: Inner-City Hospital Experience, Detroit, MI
por: Balanchivadze, Nino, et al.
Publicado: (2020)

Prediction of COVID-19 Mortality in Patients with Cancer
por: Mantha, Simon, et al.
Publicado: (2020)

ABO Blood Type and Outcomes in a Diverse COVID-19 Infected Population
por: Paul, Sonal, et al.
Publicado: (2020)

Four-Fold Increased Mortality from Sars-Cov-2 Infection in Patients with Hematologic Versus Non-Hematologic Malignancies Treated at the Largest Tertiary COVID-19 Center in Chicago/Rush University Medical Center (March 1, 2020-December 31,2020)
por: Yun, Nicole K., et al.
Publicado: (2021)

Comparison of Clinical and Thrombotic Outcomes in Sars-Cov-2- Pneumonia Versus Other Viral Pneumonia in an Urban Academic Medical Center
por: Goldberg, Rachel N., et al.
Publicado: (2021)

ERN-EuroBloodNet European Registry of Patients Affected by Red Blood Cell Disorders and COVID-19
por: Velasco, Pablo, et al.
Publicado: (2021)

Immature Platelets and Disease Severity in Patients Hospitalized with Acute COVID-19 Who Are Vaccinated Against COVID-19
por: Lee, Nicholas C.J., et al.
Publicado: (2021)

Comparison of Characteristics and Laboratory Tests of COVID 19-Hematological Patients from France and Brazil: Identification of Prognostic Driven Profiles
por: Alves, Lucas Bassolli de Oliveira, et al.
Publicado: (2021)

Outcomes of Patients with Hematologic Malignancies and COVID-19: Perspective of a Large Hematology Center in Greece
por: Spyridis, Nikolaos, et al.
Publicado: (2021)

Ethnic Variation in Hospitalized COVID-19 Patients and Correlation with Coagulopathy, Thrombosis, Prognosis and 30 Day Mortality Outcomes in California's Central Valley
por: Huang, Charity A, et al.
Publicado: (2021)

Final Results of CHRONOS19 Observational Study in Patients with Hematologic Disease and COVID-19 in Russia
por: Gavrilina, Olga A., et al.
Publicado: (2021)

Clinical Profile and Outcome of COVID Positive Hematology Patients during the COVID-19 Pandemic - an Analytical Cross Sectional Study from a Tertiary Care Centre in India
por: Kassim, Faisal, et al.
Publicado: (2021)

Middle East Respiratory Syndrome (MERS) Infection in Hematological and Oncological Patients: A Case Series from a Tertiary Care Center in Saudi Arabia
por: Alaskar, Ahmed, et al.
Publicado: (2019)

HTLV COMO FATOR DE RISCO E GRAVIDADE AO COVID-19 - RELATO DE DOIS CASOS
por: Carvalho, L.G., et al.
Publicado: (2020)

COVID-19 Outcomes in Individuals with Sickle Cell Disease and Sickle Cell Trait Compared to Blacks without Sickle Cell Disease or Trait
por: Singh, Ashima, et al.
Publicado: (2020)

The Telemedicine Experience for Individuals with Sickle Cell Disease
por: Weiss, Sara, et al.
Publicado: (2021)

COVID Symptoms and COVID Anxiety in Sickle Cell Disease
por: Smith, Wally R, et al.
Publicado: (2020)

Impact of the COVID19 Pandemic on Admissions and Emergency Department Visits of Adults with Sickle Cell Disease
por: Cohen, Alice J.
Publicado: (2020)

Effects of the COVID-19 Pandemic on Caregivers of Young Children with Sickle Cell Disease Enrolled in the Engage-HU Trial
por: Hood, Anna M, et al.
Publicado: (2021)

Critical Telehealth and Healthcare Utilization during COVID-19 in Sickle Cell Disease: CBO Reach in Understanding the Patient Experience
por: Fields, Jennifer, et al.
Publicado: (2020)

Impact of COVID 19 Pandemic on Health Care Utilization for Patients with Sickle Cell Disease - a Specialty Treatment Center Experience
por: Jain, Akshat, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_q14ovurvc3dp4b9vv9brhd18pf